| Pharmaceutical Information |
| Drug Name |
Stavudine |
| Drug ID |
BADD_D02068 |
| Description |
A dideoxynucleoside analog that inhibits reverse transcriptase and has in vitro activity against HIV. |
| Indications and Usage |
For the treatment of human immunovirus (HIV) infections. |
| Marketing Status |
Prescription; Discontinued |
| ATC Code |
J05AF04 |
| DrugBank ID |
DB00649
|
| KEGG ID |
D00445
|
| MeSH ID |
D018119
|
| PubChem ID |
18283
|
| TTD Drug ID |
D0Z8EX
|
| NDC Product Code |
65862-047; 68554-0045; 65862-046; 65862-111; 65015-672; 65862-112; 68554-0015; 65015-795; 53104-0111; 65862-263; 65862-342 |
| Synonyms |
Stavudine | D4T | 2',3'-Didehydro-3'-deoxythymidine | 2',3' Didehydro 3' deoxythymidine | 2',3'-Didehydro-2',3'-dideoxythmidine | Zerit | BMY-27857 | BMY 27857 | BMY27857 | Stavudine, Monosodium Salt |
|
| Chemical Information |
| Molecular Formula |
C10H12N2O4 |
| CAS Registry Number |
3056-17-5 |
| SMILES |
CC1=CN(C(=O)NC1=O)C2C=CC(O2)CO |
| Chemical Structure |
|
|
| ADR Related Proteins Induced by Drug |
| ADR Term |
Protein Name |
UniProt AC |
TTD Target ID |
PMID |
| Not Available | Not Available | Not Available | Not Available | Not Available |
|
| ADRs Induced by Drug |
|
|
